Hoffman W H, Sahasrananan P, Ferandos S S, Burek C L, Rose N R
J Clin Endocrinol Metab. 1982 Feb;54(2):354-6. doi: 10.1210/jcem-54-2-354.
A thyrotoxic infant was delivered to a woman with a long-standing history of Hashimoto's thyroiditis, but with no evidence of Graves' disease. Long-acting thyroid stimulator (LATS) and LATS protector were absent, but thyroid-stimulating antibody was transiently present in the infant and markedly and persistently elevated in the mother. It is concluded that the maternal level of thyroid-stimulating immunoglobulins determines the presence and duration of transient neonatal thyrotoxicosis, and that thyroid-stimulating antibody is distinct from LATS and LATS protector.
一名患有毒性弥漫性甲状腺肿的婴儿出生于一位有桥本甲状腺炎病史的女性,但无格雷夫斯病证据。婴儿体内不存在长效甲状腺刺激素(LATS)和LATS保护因子,但甲状腺刺激抗体在婴儿体内短暂存在,而在母亲体内显著且持续升高。得出的结论是,母体甲状腺刺激免疫球蛋白水平决定了短暂性新生儿甲状腺毒症的存在及持续时间,且甲状腺刺激抗体与LATS和LATS保护因子不同。